Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials. Mortensen ACL, Mohajershojai T, Gustafsson A, Berglund H, et al. J Nucl Med 2026;67:269-275.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mortensen ACL, Mohajershojai T, Gustafsson A, Berglund H, et al. Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials. J Nucl Med 2026;67:269-275.
PMID: 41198237